
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-09-23 | Valerie Hoyle(D-OR04) | house | Sale | $1,001 - $15,000 |
| 2022-11-30 | Susie Lee(D-NV03) | house | Sale | $1,001 - $15,000 |
| 2021-06-21 | Susie Lee(D-NV03) | house | Purchase | $1,001 - $15,000 |
| 2021-06-10 | Susie Lee(D-NV03) | house | Purchase | $1,001 - $15,000 |
| 2020-11-06 | Susie Lee(D-NV03) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4715.00T+6.2% | $4439.00T+0.5% | $4417.00T+0.1% | $4411.00T-7.4% | $4764.00T |
| Cost of sales | $2122.00T+5.9% | $2003.00T+3.7% | $1931.00T+0.9% | $1913.00T-10.3% | $2132.00T |
| Gross Profit | $2593.00T+6.4% | $2436.00T-2.0% | $2486.00T | — | — |
| Research and development | $368.00T+7.0% | $344.00T+5.2% | $327.00T+1.9% | $321.00T-13.0% | $369.00T |
| Marketing, selling and administrative | $1430.00T+8.8% | $1314.00T+2.3% | $1285.00T+1.6% | $1265.00T-9.8% | $1403.00T |
| Amortization of intangible assets | $543.00T+3.0% | $527.00T-3.8% | $548.00T+3.8% | $528.00T-5.0% | $556.00T |
| Asset impairment, restructuring and other special charges | $237.00T+58.0% | $150.00T+18.1% | $127.00T-30.6% | $183.00T-71.1% | $634.00T |
| Goodwill impairment | $0 | $0-100.0% | $1042.00T | $0 | $0 |
| Gain on divestiture | $0+100.0% | -$640.00T | $0 | $0 | — |
| Interest expense, net of capitalized interest | $220.00T-6.4% | $235.00T-15.2% | $277.00T+14.9% | $241.00T+2.1% | $236.00T |
| Other expense, net | $19.00T+5.6% | $18.00T-76.0% | $75.00T+134.4% | $32.00T+540.0% | $5.00T |
| (Loss) income before income taxes | -$224.00T-145.9% | $488.00T+140.8% | -$1195.00T | — | — |
| Income tax expense | $8.00T-94.7% | $150.00T+316.7% | $36.00T+500.0% | $6.00T | — |
| Net (loss) income | -$232.00T-168.6% | $338.00T+127.5% | -$1231.00T | — | — |
| Basic (usd per share) | -$470K-169.1% | $680K+127.2% | -$2.5M-1462.5% | -$160K+83.8% | -$990K |
| Diluted (usd per share) | -$470K-169.1% | $680K+127.2% | -$2.5M-1462.5% | -$160K+83.8% | -$990K |
| Basic (in shares) | $496.4M+0.5% | $494.0M+0.3% | $492.3M+0.8% | $488.3M+0.2% | $487.2M |
| Diluted (in shares) | $496.4M-0.2% | $497.3M+1.0% | $492.3M+0.8% | $488.3M+0.2% | $487.2M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Jim Cramer Says “You’ve Got a Winner in CCJ”
Option Care (OPCH) Q1 Earnings Beat Estimates
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for
/C O R R E C T I O N -- Elanco Animal Health/